Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
T.N. Dickinson's is a legacy healthcare brand recognized for its clinical-grade witch hazel products used in first aid and personal care. Established in 1866 by Thomas Newton Dickinson, the company pioneered the commercial distillation of witch hazel (Hamamelis virginiana) to create high-purity astringents. Today, it produces a variety of over-the-counter (OTC) products, including 100% natural astringents, cleansing pads, and hemorrhoidal treatments that meet USP standards. The brand is distinguished by its "blue label" positioning as a multi-benefit skin treatment for cleansing, soothing, and treating minor inflammatory conditions. It currently operates as a flagship brand under Dickinson Brands Inc., maintaining a dominant presence in the global retail market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on T.N. Dickinson's.